GRISNILIMAB SETARITOX
UNII ES6SG61M8L

Substance Identification & Data

This profile provides standardized clinical and technical data for Grisnilimab Setaritox, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ES6SG61M8L.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2361013-29-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

ES6SG61M8L

CAS Registry Number

2361013-29-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

GRISNILIMAB SETARITOX

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C175793

National Cancer Institute reference terminology for clinical and research data.

INN ID

11488

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Grisnilimab Setaritox. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GRISNILIMAB SETARITOX

Common Names & Synonyms

GRISNILIMAB SETARITOX [INN]

IMMUNOGLOBULIN G2A, ANTI-(HUMAN CD7 ANTIGEN) (MUS MUSCULUS MONOCLONAL WT1 .GAMMA.2A-CHAIN), DISULFIDE WITH MUS MUSCULUS MONOCLONAL WT1 .LAMBDA.-CHAIN, DIMER, N6-(4-(1-MERCAPTOETHYL) BENZOYL) 260-DISULFIDE WITH RICIN A CHAIN (METHIONYL) (RECOMBINANT RICINUS COMMUNIS)

IMMUNOGLOBULIN G2A-LAMBDA, ANTI-(CD7 (CD7ANTIGEN (P41),GP40, LEU-9, TP41, TP40)), MUS MUSCULUS MONOCLONAL ANTIBODY CONJUGATED TO RICIN TOXIN A (RTA)

External Clinical & Regulatory Resources

Previous UNIIES6A12WT0E

Next UNIIES73FRK6MY